×
About 23,720 results

ALLMedicine™ Estradiol Center

Research & Reviews  7,832 results

Acute estradiol and progesterone therapy in hospitalised adults to reduce COVID-19 seve...
https://doi.org/10.1136/bmjopen-2021-053684
BMJ Open; Lovre D, Bateman K et. al.

Dec 2nd, 2021 - As of November 2021, COVID-19 has killed more than 5 million people globally, including over 750 000 in the USA. Apart from corticosteroids, most available therapeutic options are at best marginally efficient in reducing disease severity and are e...

A Study Comparing Estradiol Vaginal Cream to Estrace® Cream in Females With Atrophic Vaginitis
https://clinicaltrials.gov/ct2/show/NCT02995694

Dec 1st, 2021 - This randomized, double-blind, placebo-controlled, parallel group, multiple-site study was designed to evaluate the therapeutic efficacy and safety of a generic Estradiol Vaginal Cream USP, 0.01% (Alvogen Pine Brook LLC) compared to the FDA Refere...

Men Moving Forward: A Lifestyle Program for African-American Prostate Cancer Survivors
https://clinicaltrials.gov/ct2/show/NCT03971591

Nov 30th, 2021 - Aim 1. To examine the efficacy of the Men Moving Forward guided intervention, as compared to a self-guided control intervention, in producing significant post-intervention changes in body composition in 200 AA PC survivors. Hypothesis: Men randomi...

Coagulation factor 5 (F5) is an estrogen-responsive gene in breast cancer cells.
https://doi.org/10.1055/a-1707-2130
Thrombosis and Haemostasis; Andresen M, Sletten M et. al.

Nov 27th, 2021 - Most breast cancers express estrogen receptor (ER) where estrogen signaling plays an important role. Cancer contributes to activation of the coagulation system leading to an imbalance in the hemostatic system, and Coagulation factor (F) V, which i...

see more →

Guidelines  2 results

Emergency contraception: no. 280 (replaces No. 131, August 2003).
https://doi.org/10.1016/j.ijgo.2012.09.006
International Journal of Gynaecology and Obstetrics: the ... Dunn S, Guilbert É et. al.

Feb 8th, 2013 - To review current knowledge about emergency contraception (EC), including available options, their modes of action, efficacy, safety, and the effective provision of EC within a practice setting. The combined estradiol-levonorgestrel (Yuzpe regimen...

Emergency contraception.
https://doi.org/10.1016/S1701-2163(16)35387-7
Journal of Obstetrics and Gynaecology Canada : JOGC = Jou... Dunn S, Guilbert É et. al.

Sep 14th, 2012 - To review current knowledge about emergency contraception (EC), including available options, their modes of action, efficacy, safety, and the effective provision of EC within a practice setting. The combined estradiol-levonorgestrel (Yuzpe regimen...

see more →

Drugs  702 results see all →

Clinicaltrials.gov  357 results

A Study Comparing Estradiol Vaginal Cream to Estrace® Cream in Females With Atrophic Vaginitis
https://clinicaltrials.gov/ct2/show/NCT02995694

Dec 1st, 2021 - This randomized, double-blind, placebo-controlled, parallel group, multiple-site study was designed to evaluate the therapeutic efficacy and safety of a generic Estradiol Vaginal Cream USP, 0.01% (Alvogen Pine Brook LLC) compared to the FDA Refere...

Men Moving Forward: A Lifestyle Program for African-American Prostate Cancer Survivors
https://clinicaltrials.gov/ct2/show/NCT03971591

Nov 30th, 2021 - Aim 1. To examine the efficacy of the Men Moving Forward guided intervention, as compared to a self-guided control intervention, in producing significant post-intervention changes in body composition in 200 AA PC survivors. Hypothesis: Men randomi...

Hybrid Molecular Imaging of ER in Breast Cancer Patients With DCIS
https://clinicaltrials.gov/ct2/show/NCT03703492

Nov 17th, 2021 - Integrated whole-body magnetic resonance imaging (MRI)-positron emission tomography (PET) scanners have recently been introduced for clinical use. This technology combines the anatomic and perfusion data obtained with Dynamic Contrast Enhanced (DC...

Study of the Safety and Contraceptive Efficacy of Relugolix Combination Therapy in Women With Uterine Fibroids or Endometriosis Who Are at Risk for Pregnancy
https://clinicaltrials.gov/ct2/show/NCT04756037

Nov 15th, 2021 - This is a single-arm, open-label, phase 3 study to assess the contraceptive efficacy of relugolix combination therapy (relugolix 40 milligrams [mg], estradiol [E2] 1 mg, and norethindrone acetate [NETA] 0.5 mg).

PROMES: A Clinical Study in Which Researchers Want to Learn More About the Safety Profile of MESIGYNA (Norethisterone Enantate 50 mg and Estradiol Valerate 5 mg) Used as a Medication to Prevent Pre...
https://clinicaltrials.gov/ct2/show/NCT03901131

Nov 15th, 2021 - Clinical study in which researchers want to learn more about the safety profile of MESIGYNA used as a medication in routine clinical practice to prevent pregnancy. In order to find this out researchers will collect historic and treatment related d...

see more →

News  593 results

Diabetes Risk Higher for Transwomen vs Cisgender Females
https://www.medpagetoday.com/endocrinology/diabetes/95937

Nov 30th, 2021 - Transwomen may face a higher risk for developing type 2 diabetes than cisgender women, a new study suggested. In a review of new data from the Study of Transition Outcomes and Gender (STRONG) cohort, transwomen had a 30% higher odds of prevalent t...

Next-Generation Endocrine Therapy Moves Forward in Breast Cancer Trial
https://www.onclive.com/view/next-generation-endocrine-therapy-moves-forward-in-breast-cancer-trial

Oct 6th, 2021 - Amcenestrant (SAR439859), a new oral form of endocrine therapy that has shown early signs of efficacy, is being evaluated against the current standards of care in patients with estrogen receptor (ER)– positive, HER2-negative locally advanced or me...

DFS Benefit Similar With Extended Intermittent or Continuous Letrozole in HR+ Breast Cancer
https://www.onclive.com/view/dfs-benefit-similar-with-extended-intermittent-or-continuous-letrozole-in-hr-breast-cancer

Aug 20th, 2021 - Extended adjuvant endocrine therapy via intermittent administration of letrozole did not improve disease-free survival vs continuous use in postmenopausal patients with hormone receptor (HR)–positive breast cancer, but represents a valid approach ...

3 cases of hormone therapy optimized to match the patient problem
https://www.mdedge.com/obgyn/article/242599/gynecology/3-cases-hormone-therapy-optimized-match-patient-problem
Robert L. Barbieri, MD

Jul 7th, 2021 - There are dozens of medications containing combinations of estrogen and progestin. I am often confused by the bewildering proliferation of generic brand names used to describe the same estrogen-progestin (E-P) regimen.

Hormone Pellet Safety Data 'Not Very Reassuring at All' for Women
https://www.medscape.com/viewarticle/953414

Jun 18th, 2021 - UPDATED June 23, 2021 // Editor's note: This story has been changed from the original version. The original version improperly stated that patients received pellets made by SottoPelle, but the company does not make hormone pellets. Women who recei...

see more →

Patient Education  2 results see all →